News
CN Bio, which offers Organ-on-a-chip systems, has formed a strategic partnership with Pharmaron, a life sciences R&D service ...
Hansa Biopharma AB announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately ...
Debiopharm and Oncodesign Services have signed a license agreement for the use of Debiopharm’s AbYlink technology for ...
Payman Khales is appointed CEO as Joseph Dziedzic will retire. Integer Holdings Corporation, a medical device contract ...
PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...
To meet growing pharmaceutical needs for biologics and complex therapeutics, EVERSANA also increased its cold chain ...
Under Shinomiya’s leadership, Asahi Kasei’s Healthcare Sector will further advance its portfolio and global presence.
The U.S. Food and Drug Administration (FDA) has approved Ferring Pharmaceuticals’ drug product manufacturing hub in Parsippany, NJ.
Galapagos, a global biotechnology company, has appointed the founding CEO of its new subsidiary & announced the search for a ...
Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.
Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s ...
Join Mike O’Mara, COO of Cellipont Bioservices, and Marcia Blackmoore, VP of Customer Operations at L7 Informatics, for a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results